[HTML][HTML] CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis
…, E Gane, J Taubel, J Kao, M Fontana… - … England Journal of …, 2021 - Mass Medical Soc
Background Transthyretin amyloidosis, also called ATTR amyloidosis, is a life-threatening
disease characterized by progressive accumulation of misfolded transthyretin (TTR) protein in …
disease characterized by progressive accumulation of misfolded transthyretin (TTR) protein in …
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis
…, AWJM Glaudemans, T Rezk, M Fontana… - Circulation, 2016 - Am Heart Assoc
Background— Cardiac transthyretin (ATTR) amyloidosis is a progressive and fatal
cardiomyopathy for which several promising therapies are in development. The diagnosis is …
cardiomyopathy for which several promising therapies are in development. The diagnosis is …
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
…, T Damy, U Eriksson, M Fontana… - European heart …, 2021 - academic.oup.com
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine rollout has coincided
with the spread of variants of concern. We investigated whether single-dose vaccination, …
with the spread of variants of concern. We investigated whether single-dose vaccination, …
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
…, T Cutino-Moguel, M Andiapen, M Fontana… - Science …, 2020 - science.org
Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2
is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody …
is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody …
Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis
M Fontana, S Pica, P Reant, A Abdel-Gadir, TA Treibel… - Circulation, 2015 - Am Heart Assoc
Background— The prognosis and treatment of the 2 main types of cardiac amyloidosis,
immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially …
immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis, are substantially …
Native T1 mapping in transthyretin amyloidosis
M Fontana, SM Banypersad, TA Treibel… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives : The aims of the study were to explore the ability of native myocardial T1
mapping by cardiac magnetic resonance to: 1) detect cardiac involvement in patients with …
mapping by cardiac magnetic resonance to: 1) detect cardiac involvement in patients with …
Immune boosting by B. 1.1. 529 (Omicron) depends on previous SARS-CoV-2 exposure
…, MO Diniz, A Ellis, K Feehan, M Finlay, M Fontana… - Science, 2022 - science.org
The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …
Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study
M Fontana, SM Banypersad, TA Treibel, A Abdel-Gadir… - Radiology, 2015 - pubs.rsna.org
Purpose To investigate cardiac magnetic resonance (MR) imaging measurements of
extracellular volume (ECV) and total cell volume in immunoglobulin light-chain amyloidosis (AL) …
extracellular volume (ECV) and total cell volume in immunoglobulin light-chain amyloidosis (AL) …
Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression
M Fontana, A Martinez-Naharro, L Chacko… - Cardiovascular …, 2021 - jacc.org
Objectives The purpose of this study was to determine the effect of patisiran on the cardiac
amyloid load as measured by cardiac magnetic resonance and extracellular volume (ECV) …
amyloid load as measured by cardiac magnetic resonance and extracellular volume (ECV) …